PDT Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,708
Closed -$505K 953
2022
Q3
$505K Sell
10,708
-20,292
-65% -$1.31M 0.08% 432
2022
Q2
$2.22M Buy
31,000
+26,500
+589% +$1.94M 0.2% 146
2022
Q1
$364K Buy
+4,500
New +$381K 0.03% 660
2021
Q4
Sell
-7,104
Closed -$621K 1052
2021
Q3
$621K Buy
+7,104
New +$643K 0.04% 420
2020
Q2
Sell
-9,300
Closed -$367K 863
2020
Q1
$367K Buy
+9,300
New +$544K 0.03% 440
2017
Q4
Sell
-52,643
Closed -$2.75M 575
2017
Q3
$2.75M Sell
52,643
-140,257
-73% -$7.82M 0.09% 245
2017
Q2
$11.3M Buy
192,900
+69,008
+56% +$3.59M 0.45% 62
2017
Q1
$5.68M Buy
123,892
+11,592
+10% +$577K 0.3% 136
2016
Q4
$5.91M Sell
112,300
-4,100
-4% -$198K 0.39% 100
2016
Q3
$5.19M Buy
116,400
+31,400
+37% +$1.36M 0.3% 137
2016
Q2
$3.24M Buy
+85,000
New +$3.73M 0.26% 153
2015
Q4
Sell
-45,251
Closed -$1.81M 1034
2015
Q3
$1.81M Sell
45,251
-52,719
-54% -$2.3M 0.04% 495
2015
Q2
$3.93M Buy
97,970
+85,654
+695% +$2.96M 0.1% 247
2015
Q1
$403K Buy
+12,316
New +$340K 0.01% 1088

Other funds holding SYNH

PDT Partners's SYNH Position: Q4 2022 in Review

PDT Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 10,708 shares — an estimated $505K sold.

PDT Partners first reported a position in SYNH in Q1 2015 and held it in 14 quarters. The position peaked at $11.3M in Q2 2017. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

  • PDT Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • PDT Partners sold 10,708 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $505K.
  • PDT Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2015 and held it in 14 quarters.
  • PDT Partners's Syneos Health, Inc. Class A Common Stock position peaked at $11.3M in Q2 2017.
  • 307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.